evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract
6508,GENE_SUMMARY,,PIK3CB encodes a kinase involved in the pro-oncogenic AKT/mTOR signaling pathway. Amplification of PIK3CB is found in various cancers. Some mutations in PIK3CB have been shown to confer resistance to PI3-kinase inhibitors.,,2017-04-26,,5291,PIK3CB,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",True,ENST00000289153,NM_006219.2,P110BETA,PI3K,PIK3C1,PI3KBETA,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6509,GENE_BACKGROUND,,"PIK3CB, also known as p110-β, is a catalytic subunit of PI3K that is important in creating phosphoinositol 3,4,5-trisphosphate (PIP3), which acts as a secondary messenger in key cellular signaling pathways such as AKT-mTOR. PIK3CB plays a critical role in tumorigenesis driven by loss of PTEN (PMID: 18755892, 18594509) and drives PI3K signaling. Roles other than oncogenic activation of PI3K/AKT pathway have also been described for PIK3CB, including effects on growth and cell metabolism, including insulin signaling (PMID: 18594509, 18780892, 26132308). In HER2-amplified and PIK3CA-mutant cancers, inhibition of PIK3CA can lead to reactivation of PI3K signaling through PIK3CB (PMID: 25544637). Hence, combined inhibition of both isoforms is a promising therapeutic strategy that blocks pathway activation and leads to successful tumor regression (PMID: 25544636, 25544637, 25409150).",,2017-10-19,,5291,PIK3CB,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",True,ENST00000289153,NM_006219.2,P110BETA,PI3K,PIK3C1,PI3KBETA,False,18755892,PTEN-deficient cancers depend on PIK3CB.,Proceedings of the National Academy of Sciences of the United States of America,2018-09-02T20:08:00,105,35,13057-62,Wee S et al,doi: 10.1073/pnas.0802655105,,0001-09-02,,18780892,Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development.,Science signaling,2018-09-09T20:08:00,True,36,ra3,Ciraolo E et al,doi: 10.1126/scisignal.1161577,,0001-09-09,,25544637,Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer.,Cancer cell,2018-01-12T20:15:00,27,True,97-108,Costa C et al,doi: 10.1016/j.ccell.2014.11.007,,2018-01-12T01:08:00,,25544636,Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ.,Cancer cell,2018-01-12T20:15:00,27,True,109-22,Schwartz S et al,doi: 10.1016/j.ccell.2014.11.008,,0001-01-12,,25409150,Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.,Nature,2018-02-12T20:15:00,518,7538,240-4,Juric D et al,doi: 10.1038/nature13948,,0001-02-12,,18594509,"Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.",Nature,2018-08-07T20:08:00,454,7205,776-9,Jia S et al,doi: 10.1038/nature07091,,0001-08-07,,26132308,Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells.,PLoS genetics,2018-07-01T20:15:00,11,7,e1005304,Guillermet-Guibert J et al,doi: 10.1371/journal.pgen.1005304,,0001-07-01,
